BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21857510)

  • 1. New approaches to the treatment of giardiasis.
    Tejman-Yarden N; Eckmann L
    Curr Opin Infect Dis; 2011 Oct; 24(5):451-6. PubMed ID: 21857510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of antigiardial drugs.
    Wright JM; Dunn LA; Upcroft P; Upcroft JA
    Expert Opin Drug Saf; 2003 Nov; 2(6):529-41. PubMed ID: 14585063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative clinical trial of albendazole versus metronidazole in giardiasis.
    Misra PK; Kumar A; Agarwal V; Jagota SC
    Indian Pediatr; 1995 Mar; 32(3):291-4. PubMed ID: 8613282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis.
    Misra PK; Kumar A; Agarwal V; Jagota SC
    Indian Pediatr; 1995 Jul; 32(7):779-82. PubMed ID: 8617554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
    Kim WJ; Korthals KA; Li S; Le C; Kalisiak J; Sharpless KB; Fokin VV; Miyamoto Y; Eckmann L
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396548
    [No Abstract]   [Full Text] [Related]  

  • 7. Giardiasis: recent progress in chemotherapy and drug development.
    Minenoa T; Avery MA
    Curr Pharm Des; 2003; 9(11):841-55. PubMed ID: 12678869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.
    Valdez CA; Tripp JC; Miyamoto Y; Kalisiak J; Hruz P; Andersen YS; Brown SE; Kangas K; Arzu LV; Davids BJ; Gillin FD; Upcroft JA; Upcroft P; Fokin VV; Smith DK; Sharpless KB; Eckmann L
    J Med Chem; 2009 Jul; 52(13):4038-53. PubMed ID: 19480409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.
    Yereli K; Balcioğlu IC; Ertan P; Limoncu E; Onağ A
    Clin Microbiol Infect; 2004 Jun; 10(6):527-9. PubMed ID: 15191380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of two phenyl-carbamate derivatives, singly and in combination with albendazole against albendazole-resistant Giardia intestinalis.
    Jiménez-Cardoso E; Flores-Luna A; Pérez-Urizar J
    Acta Trop; 2004; 92(3):237-44. PubMed ID: 15533293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giardiasis: a pharmacotherapy review.
    Escobedo AA; Cimerman S
    Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.
    Lalle M
    Infect Disord Drug Targets; 2010 Aug; 10(4):283-94. PubMed ID: 20429863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of chronic Giardia infection.
    Escobedo AA; Hanevik K; Almirall P; Cimerman S; Alfonso M
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1143-57. PubMed ID: 25059638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.
    Tejman-Yarden N; Miyamoto Y; Leitsch D; Santini J; Debnath A; Gut J; McKerrow JH; Reed SL; Eckmann L
    Antimicrob Agents Chemother; 2013 May; 57(5):2029-35. PubMed ID: 23403423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran.
    Alizadeh A; Ranjbar M; Kashani KM; Taheri MM; Bodaghi M
    East Mediterr Health J; 2006 Sep; 12(5):548-54. PubMed ID: 17333792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Randomized study comparing the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children].
    Romero-Cabello R; Robert L; Muñoz-García R; Tanaka J
    Rev Latinoam Microbiol; 1995; 37(4):315-23. PubMed ID: 8900567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis].
    Cacopardo B; Patamia I; Bonaccorso V; Di Paola O; Bonforte S; Brancati G
    Clin Ter; 1995 Dec; 146(12):761-7. PubMed ID: 8681495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: a randomized open clinical trial.
    Hanevik K; Mørch K; Eide GE; Langeland N; Hausken T
    Scand J Infect Dis; 2008; 40(6-7):517-22. PubMed ID: 18584540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.